Toll-like receptor signaling in endogenous neuroprotection and stroke - PubMed (original) (raw)

Review

Toll-like receptor signaling in endogenous neuroprotection and stroke

B J Marsh et al. Neuroscience. 2009.

Abstract

Stroke and other cerebral vascular diseases are a leading cause of morbidity and mortality in the United States. Despite intensive research to identify interventions that lessen cerebrovascular injury, no major therapies exist. Development of stroke prophylaxis involves an understanding of the mechanisms of damage following cerebral ischemia, and elucidation of the endogenous mechanisms that combat further brain injury. Toll-like receptors (TLRs) are critical components of the innate immune system that have been shown recently to mediate ischemic injury. Paradoxically, TLR ligands administered systemically induce a state of tolerance to subsequent ischemic injury. Herein we suggest that stimulation of TLRs prior to ischemia reprograms TLR signaling that occurs following ischemic injury. Such reprogramming leads to suppressed expression of pro-inflammatory molecules and enhanced expression of numerous anti-inflammatory mediators that collectively confer robust neuroprotection. Our findings indicate that numerous preconditioning stimuli lead to TLR activation, an event that occurs prior to ischemia and ultimately leads to TLR reprogramming. Thus genomic reprogramming of TLR signaling may be a unifying principle of tolerance to cerebral ischemia.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Toll-like receptor signaling

Figure 2

Figure 2

Cerebral ischemia induces Toll-like receptor signaling

Figure 3

Figure 3

Preconditioning up-regulates inhibitors of TLR proinflammatory pathways

Figure 4

Figure 4

Preconditioning reprograms TLR signaling following cerebral ischemia

Similar articles

Cited by

References

    1. Ahmed S, He Y, Nassief A, Xu J, Xu X, Hsu C. Effects of Lipopolysaccharide priming on acute ischemic brain injury. Stroke. 2000;31:193–199. - PubMed
    1. Aneja R, Odoms K, Dunsmore K, Shanley TP, Wong HR. Extracellular heat shock protein-70 induces endotoxin tolerance in THP-1 cells. J Immunol. 2006;177:7184–7192. - PubMed
    1. Bagchi A, Herrup EA, Warren HS, Trigilio J, Shin HS, Valentine C, Hellman J. MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists. J Immunol. 2007;178:1164–1171. - PubMed
    1. Bastide M, Gele P, Petrault O, Pu Q, Caliz A, Robin E, Deplanque D, Duriez P, Bordet R. Delayed cerebrovascular protective effect of lipopolysaccharide in parallel to brain ischemic tolerance. J Cereb Blood Flow Metab. 2003;23:399–405. - PubMed
    1. Bond R, Rerkasem K, Shearman CP, Rothwell PM. Time trends in the published risks of stroke and death due to endarterectomy for symptomatic carotid stenosis. Cerebrovasc Dis. 2004;18:37–46. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources